Insight Molecular Diagnostics Inc. (IMDX) Scorecard
- 2026-Q2: Total return Win; Revenue growth Lose; EPS growth Lose.
- 2026-Q1: Total return Lose; Revenue growth Lose; EPS growth Lose.
- 2025-Q4: Total return Win; Revenue growth Win; EPS growth Lose.
- 2025-Q3: Total return Win; Revenue growth Win; EPS growth Lose.
24/70
1.7 / 5 stars
All 70 Win/Lose results and 50 gray no-data contests shown below
Every strict quarterly win earns 1 point. A loss or tie earns 0. A contest with no data is a gray cell, neither a win nor a loss, and leaves the total: stars are 5 × points won ÷ contests with data.
Trailing 1 year (4 quarters): 5 wins, 7 lossesLast fetched: 4 Sept 2026
Complete point ledger
Each cell identifies the missing side explicitly.
| Quarter | Total return | Revenue growth | EPS growth |
|---|---|---|---|
| 2026-Q21/3 |
WinIMDX / S&P 79.88% / 15.20% |
LoseIMDX / S&P -60.77% / 15.00% |
LoseIMDX / S&P -60.68% / 50.40% |
| 2026-Q10/3 |
LoseIMDX / S&P -56.27% / -4.33% |
LoseIMDX / S&P -49.28% / 11.30% |
LoseIMDX / S&P -61.54% / 27.70% |
| 2025-Q42/3 |
WinIMDX / S&P 125.90% / 2.65% |
WinIMDX / S&P 115.58% / 9.00% |
LoseIMDX / S&P -65.62% / 13.40% |
| 2025-Q32/3 |
WinIMDX / S&P 9.93% / 8.12% |
WinIMDX / S&P 520.87% / 4.61% |
LoseIMDX / S&P -29.52% / 13.45% |
| 2025-Q21/3 |
LoseIMDX / S&P -1.31% / 10.94% |
WinIMDX / S&P 316.13% / 4.83% |
LoseIMDX / S&P -12.13% / 10.63% |
| 2025-Q12/3 |
WinIMDX / S&P 28.57% / -4.27% |
WinIMDX / S&P 178.08% / 4.98% |
LoseIMDX / S&P -23.23% / 10.57% |
| 2024-Q42/3 |
LoseIMDX / S&P -16.49% / 2.41% |
WinIMDX / S&P 25.15% / 5.25% |
WinIMDX / S&P 34.37% / 6.15% |
| 2024-Q30/3 |
LoseIMDX / S&P -3.39% / 5.89% |
LoseIMDX / S&P -51.54% / 5.89% |
LoseIMDX / S&P -52.26% / 6.11% |
| 2024-Q20/3 |
LoseIMDX / S&P 0.68% / 4.28% |
LoseIMDX / S&P -7.08% / 5.38% |
LoseIMDX / S&P -57.66% / 5.12% |
| 2024-Q12/3 |
WinIMDX / S&P 17.20% / 10.56% |
WinIMDX / S&P 57.94% / 5.71% |
LoseIMDX / S&P -52.66% / 5.59% |
| 2023-Q41/3 |
LoseIMDX / S&P -19.87% / 11.69% |
WinIMDX / S&P 56.89% / 6.81% |
LoseIMDX / S&P -68.42% / 7.78% |
| 2023-Q30/2 |
LoseIMDX / S&P -32.17% / -3.27% |
LoseIMDX / S&P -216.48% / 7.52% |
No dataIMDX / S&P / -5.03% |
| 2023-Q20/2 |
LoseIMDX / S&P -35.03% / 8.74% |
LoseIMDX / S&P -424.78% / 9.50% |
No dataIMDX / S&P / -8.57% |
| 2023-Q11/2 |
WinIMDX / S&P 10.28% / 7.50% |
LoseIMDX / S&P -39.82% / 10.77% |
No dataIMDX / S&P / -15.69% |
| 2022-Q40/2 |
LoseIMDX / S&P -56.03% / 7.56% |
LoseIMDX / S&P -56.41% / 11.88% |
No dataIMDX / S&P / -17.99% |
| 2022-Q30/2 |
LoseIMDX / S&P -18.89% / -4.88% |
LoseIMDX / S&P -127.06% / 13.47% |
No dataIMDX / S&P / -1.41% |
| 2022-Q20/2 |
LoseIMDX / S&P -39.60% / -16.10% |
LoseIMDX / S&P -108.05% / 13.71% |
No dataIMDX / S&P / 11.04% |
| 2022-Q10/2 |
LoseIMDX / S&P -31.34% / -4.60% |
LoseIMDX / S&P -37.46% / 15.97% |
No dataIMDX / S&P / 42.23% |
| 2021-Q41/2 |
LoseIMDX / S&P -39.04% / 11.03% |
WinIMDX / S&P 80.61% / 15.00% |
No dataIMDX / S&P / 96.40% |
| 2021-Q30/1 |
LoseIMDX / S&P -37.98% / 0.58% |
No dataIMDX / S&P / 10.77% |
No dataIMDX / S&P / 69.42% |
| 2021-Q21/1 |
WinIMDX / S&P 10.60% / 8.55% |
No dataIMDX / S&P / 6.58% |
No dataIMDX / S&P / 51.81% |
| 2021-Q11/1 |
WinIMDX / S&P 117.15% / 6.17% |
No dataIMDX / S&P / -1.06% |
No dataIMDX / S&P / 7.39% |
| 2020-Q41/1 |
WinIMDX / S&P 71.94% / 12.15% |
No dataIMDX / S&P / -3.72% |
No dataIMDX / S&P / -33.42% |
| 2020-Q30/1 |
LoseIMDX / S&P -27.23% / 8.93% |
No dataIMDX / S&P / -2.04% |
No dataIMDX / S&P / -27.10% |
| 2020-Q20/1 |
LoseIMDX / S&P -22.04% / 20.54% |
No dataIMDX / S&P / -0.46% |
No dataIMDX / S&P / -27.11% |
| 2020-Q11/1 |
WinIMDX / S&P 8.89% / -19.60% |
No dataIMDX / S&P / 3.47% |
No dataIMDX / S&P / -14.75% |
| 2019-Q40/1 |
LoseIMDX / S&P 7.14% / 9.07% |
No dataIMDX / S&P / 5.36% |
No dataIMDX / S&P / 2.99% |
| 2019-Q30/1 |
LoseIMDX / S&P -15.66% / 1.70% |
No dataIMDX / S&P / 5.02% |
No dataIMDX / S&P / 0.21% |
| 2019-Q20/1 |
LoseIMDX / S&P -36.96% / 4.30% |
No dataIMDX / S&P / 6.64% |
No dataIMDX / S&P / 8.65% |
| 2019-Q11/1 |
WinIMDX / S&P 186.23% / 13.65% |
No dataIMDX / S&P / 8.12% |
No dataIMDX / S&P / 14.29% |
| 2018-Q40/1 |
LoseIMDX / S&P -44.80% / -13.52% |
No dataIMDX / S&P / 9.05% |
No dataIMDX / S&P / 18.23% |
| 2018-Q30/1 |
LoseIMDX / S&P -1.96% / 7.71% |
No dataIMDX / S&P / 10.21% |
No dataIMDX / S&P / 19.06% |
| 2018-Q21/1 |
WinIMDX / S&P 21.43% / 3.43% |
No dataIMDX / S&P / 9.03% |
No dataIMDX / S&P / 14.46% |
| 2018-Q10/1 |
LoseIMDX / S&P -54.84% / -0.76% |
No dataIMDX / S&P / 7.68% |
No dataIMDX / S&P / 12.46% |
| 2017-Q40/1 |
LoseIMDX / S&P -38.41% / 6.64% |
No dataIMDX / S&P / 7.03% |
No dataIMDX / S&P / 13.82% |
| 2017-Q31/1 |
WinIMDX / S&P 45.19% / 4.48% |
No dataIMDX / S&P / 5.68% |
No dataIMDX / S&P / 17.57% |
| 2017-Q20/1 |
LoseIMDX / S&P -12.61% / 3.09% |
No dataIMDX / S&P / 4.83% |
No dataIMDX / S&P / 17.74% |
| 2017-Q10/1 |
LoseIMDX / S&P -15.60% / 6.07% |
No dataIMDX / S&P / 3.67% |
No dataIMDX / S&P / 13.32% |
| 2016-Q41/1 |
WinIMDX / S&P 39.88% / 3.82% |
No dataIMDX / S&P / 2.09% |
No dataIMDX / S&P / 7.05% |
| 2016-Q31/1 |
WinIMDX / S&P 41.57% / 3.85% |
No dataIMDX / S&P / 0.20% |
No dataIMDX / S&P / -3.15% |
Dividend-reinvested, split-adjusted total return
1Y · 2025-08-29 to 2026-08-27
| Metric | IMDX total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | 69.57% | 20.78% |
| Annualized return | 69.57% | 20.78% |
5Y · 2021-09-01 to 2026-08-27
| Metric | IMDX total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -94.84% | 83.14% |
| Annualized return | -44.73% | 12.86% |
10Y · 2016-09-01 to 2026-08-27
| Metric | IMDX total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -94.03% | 319.30% |
| Annualized return | -24.55% | 15.41% |
Calculation rules
- window
- Latest 40 completed benchmark quarters; unavailable issuer evidence remains visible and scores 0.
- return Basis
- Issuer adjusted close reinvests distributions and normalizes splits; the S&P 500 Total Return Index is the direct benchmark.
- point Rule
- Strict same-quarter win = 1. Loss, tie or unavailable evidence = 0. No partial or subjective points.
- frequency
- Quarter endpoints only.
- fundamentals
- Trailing-four-quarter issuer revenue and EPS growth use the issuer's normalized government-filed facts.
- non Scoring
Snapshot captured 2026-09-04.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |